MedPath
NMPA Approval

Naloxone Hydrochloride for Injection

国药准字H20060061

November 26, 2020

Drug Information

注射用盐酸纳洛酮

健天能

注射剂

0.4mg

化学药品

November 26, 2020

Company Information

Applicant Company

Manufacturing Company

重庆市北碚区京东方大道66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸纳洛酮 - NMPA 批准文号 | MedPath